Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Pain. 2019 May;160(5):1119–1130. doi: 10.1097/j.pain.0000000000001491

Table 1.

Differences in demographic and clinical characteristics between the groups.

No Chronic Pain (n=14) Chronic Pain (n=33) p-value
Chronological Age, mean ± SD years 71.5 ± 7.3 70.6 ± 5.5 0.647
Predicted Brain Age, mean ± SD years 67.8 ± 10.6 69.4 ± 8.6 0.592
Sex, no. (%) 0.076*
Male 6 (52.6) 6 (18.2)
Female 8 (47.4) 27 (81.8)
Race, no. (%) 0.304*
Caucasian 13 (92.9) 30 (90.9)
African American 0 (0) 2 (6.1)
Asian/Pacific Islander 1 (7.1) 0 (0)
Other 0 (0) 1 (3.0)
Education, no. (%) 0.133*
High school 2 (14.3) 11 (33.3)
Two-year 1 (7.1) 7 (21.2)
Four-year 2 (14.3) 7 (21.2)
Masters 7 (50.0) 6 (18.2)
Doctorate 2 (14.3) 2 (6.1)
CES-D, mean ± SD years 5.9 ± 5.0 8.8 ± 5.4 0.085*
3MS, mean ± SD years 99.1 ± 1.3 97.3 ± 3.4 0.008*
Duration of Pain, mean ± SD years - 6.3 ± 8.8 -
Worst Pain Intensity - 5.2 ± 1.9 -
# of Anatomical Pain Sites - 3.1 ± 2.2 -
Medications, no. (%) 5 (38.5) 16 (48.5) 0.421*
Narcotic Medications (PRN), no. (%) 0 (0) 6 (18.2) 0.088*
Antidepressant Medications, no. (%) 1 (7.1) 9 (27.3) 0.123*
Anticonvulsant Medications, no. (%) 0 (0) 4 (12.1) 0.173*
NSAID Medications, no. (%) 4 (28.6) 16 (48.5) 0.207*
*

X2